Zimmer Biomet Robotics

Zimmer Biomet Robotics, formerly Medtech SA, is a robotic surgery company founded in 2002 by Bertin Nahum and based in Montpellier, France (Hérault department, in southern France. This company designs, develops and markets robotic assistance for surgical procedures of the central nervous system and other applications such as the knee.

This article is about the medical robotics company. For other uses, see Medtech (disambiguation).
Zimmer Biomet Robotics
IndustryMedical Devices
Founded2002
FounderBertin Nahum, Founder & President (2002-2017)[1]
Headquarters
Montpellier
,
France
Products
  • Rosa Knee
  • Rosa One Brain
  • Rosa One Spine
Websitewww.zimmerbiomet.com/en/products-and-solutions/zb-edge/robotics.html

The company went public in a November 2013 with an initial public offering on Euronext Paris. Its ticker symbol and flagship product is ROSA, a robotic surgical assistant designed for minimally-invasive surgery.

Its pre-IPO investors include Newfund, which had acquired 27 percent of Medtech's capital in 2010,[2] Soridec, and Midi Capital.[3]

History

The first surgical robot developed by Medtech, in partnership with the Montpellier Laboratory of Computer Science, Robotics and Microelectronics (LIRMM), was BRIGIT, a robot dedicated to knee surgery. In 2006, Zimmer, the world leader in orthopedic implants, bought BRIGIT’s entire patent portfolio.

Medtech decided to reinvest those resources in the development of a new robotic-assisted technology. Medtech’s first ROSA robot, ROSA Brain, dedicated to neurosurgery was thus designed. Comparable to a "GPS" for the brain, the robot can be used for any type of cranial procedures requiring surgical planning with preoperative data, patient registration and precise positioning and handling of instruments.[4]

Pathologies covered by the use of ROSA Brain include epilepsy, Parkinson's disease, generalized dystonia, cavernoma, hydrocephalus.[5]

The ROSA Brain device is present in 120 hospitals across Europe, North America, Asia and the Middle East[6] and has been used in more than 9 000 surgical procedures.[7]

In July 2014, Medtech announced the CE Marking of its new product ROSA Spine, allowing it to be marketed in Europe.[8]

On November 28, 2013, Medtech was listed on the French stock Exchange operated by Euronext (NYSE Euronext, compartment C).[9]

In 2016, Medtech obtained the CE marking for its new product ROSA One, a robotic assistive device for minimally invasive surgery of the brain and the spine in the same platform.

In July 2016, Medtech was acquired by the Zimmer Biomet Group and became as known as Zimmer Biomet Robotics.

References
  1. Gagliardi, Julien (27 February 2014). "Bertin Nahum – Medtech : "La France est un lieu d'excellence pour la robotique chirurgicale"". Atlantico (in French). Retrieved 1 March 2014.
  2. "Medtech ouvre son capital à Newfund". La Tribune Occitanie-Montpellier. 3 May 2010.
  3. "Investors". Medtech company website.
  4. Medtech’s official website : "Medtech - Rosa™". Archived from the original on 2014-08-22. Retrieved 2014-07-30.
  5. Medtech’s official website : "Medtech - Variety of disease". Archived from the original on 2014-11-04. Retrieved 2014-07-30.
  6. Medtech’s official website : "Medtech - ROSA™ worldwide". Archived from the original on 2014-11-03. Retrieved 2014-07-30.
  7. Article from the French journal Echos.fr (November 2013) : http://www.lesechos.fr/entreprises-secteurs/innovateurs/0203121063320-le-robot-chirurgical-de-medtech-va-conquerir-les-etats-unis-629589.php
  8. Medtech’s official website : "Medtech - Medtech Receives CE Marking of ROSA Spine Robot". Archived from the original on 2014-07-30. Retrieved 2014-07-30.
  9. NYSE News Release (28 November 2013) : "NYSE, New York Stock Exchange > About Us > News & Events > News Releases > Press Release 11-29-2013". Archived from the original on 2014-08-08. Retrieved 2014-07-30.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.